FDA-Drug2024-10-23Class I
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
Bionpharma Inc.
Hazard
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
Sold states
Nationwide in the U.S.A.
Affected count
1,980 bottles
Manufactured in
400 Alexander Park Ste 2-4b, Princeton, NJ, United States
Products
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0012-2025Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief